SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $135,000 | -78.1% | 1,807 | -50.0% | 0.00% | – |
| Q4 2020 | $616,000 | +660.5% | 3,614 | +499.3% | 0.00% | – |
| Q3 2020 | $81,000 | -16.5% | 603 | 0.0% | 0.00% | – |
| Q2 2020 | $97,000 | +155.3% | 603 | +61.2% | 0.00% | – |
| Q1 2020 | $38,000 | -79.1% | 374 | -68.9% | 0.00% | – |
| Q2 2019 | $182,000 | -34.1% | 1,201 | -48.2% | 0.00% | – |
| Q1 2019 | $276,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |